articleTop 1% cited
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
The Lancet Oncology · 2008 · Vol. 9(3) · pp. 215–221
Wasaburo Koizumi✉(Kitasato University)Hiroyuki Narahara(Osaka Medical Center for Cancer and Cardiovascular Diseases)Takuo Hara(Kouseiren Takaoka Hospital)Akinori Takagane(Iwate Medical University)Toshikazu AkiyaMasakazu Takagi(Shizuoka General Hospital)Kosei Miyashita(Nagasaki Medical Center)Takashi Nishizaki(Matsuyama Red Cross Hospital)Osamu Kobayashi(Kanagawa Prefectural Hospital Organization)Wataru Takiyama(Hiroshima City Asa Citizens Hospital)Yasushi Toh(National Hospital Organization Kyushu Cancer Center)Takashi Nagaie(Aso Iizuka Hospital)Seiichi Takagi(Kanagawa Cancer Center)Yoshitaka Yamamura(Aichi Cancer Center)Kimihiko Yanaoka(Wakayama Medical University)Hiroyuki OritaMasahiro Takeuchi(Kitasato University)
Gastric Cancer Management and OutcomesHelicobacter pylori-related gastroenterology studiesColorectal Cancer Treatments and StudiesMedicineCisplatinClinical endpointCancerChemotherapyInternal medicineClinical trialPhases of clinical researchRandomized controlled trialNausea
MeSH terms
AdultAgedAntimetabolites, AntineoplasticAntineoplastic AgentsCisplatinDrug Administration ScheduleDrug CombinationsFemaleTegafurHumansJapanMaleMiddle AgedOxonic AcidStomach Neoplasms
Funding
- Taiho Pharmaceutical
Citations
1,863
FWCI
88.47
field-weighted impact
References
29
Percentile
100%
vs. same field & year
Citations per year
Cited by
Chemotherapy for advanced gastric cancer
Cochrane Database of Systematic Reviews · 2017 · 1,287 citations
Advanced gastric cancer: Current treatment landscape and future perspectives
World Journal of Gastroenterology · 2016 · 577 citations
Treatment of gastric cancer
World Journal of Gastroenterology · 2014 · 626 citations
Cisplatin in cancer therapy: Molecular mechanisms of action
European Journal of Pharmacology · 2014 · 5,353 citations
Characteristics of gastric cancer in Asia
World Journal of Gastroenterology · 2014 · 406 citations
Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
European Journal of Cancer · 2011 · 611 citations
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Annals of Oncology · 2022 · 1,260 citations
References
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer
British Journal of Cancer · 1995 · 794 citations
Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patients
European Journal of Cancer · 1998 · 564 citations
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
Journal of Clinical Oncology · 2006 · 1,929 citations
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
Journal of Clinical Oncology · 2006 · 3,448 citations
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
JNCI Journal of the National Cancer Institute · 2000 · 15,689 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.